MOLOGEN AG

Release Summary

The biotech company MOLOGEN AG (ISIN DE0006637200; Frankfurt Stock Exchange Prime Standard: MGN) announced today first preliminary data on its EnanDIM® technology in a murine tumor model.

MOLOGEN AG